{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T07:22:11Z","timestamp":1744183331725,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":25,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493933853"},{"type":"electronic","value":"9781493933877"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3387-7_24","type":"book-chapter","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T11:08:16Z","timestamp":1460632096000},"page":"433-444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An Approach to Identify and Characterize a Subunit Candidate Shigella Vaccine Antigen"],"prefix":"10.1007","author":[{"given":"Debasis","family":"Pore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj K.","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"key":"24_CR1","first-page":"651","volume":"77","author":"KL Kotloff","year":"1999","unstructured":"Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD et al (1999) Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 77:651\u2013666","journal-title":"Bull World Health Organ"},{"key":"24_CR2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/jac\/dkg080","volume":"51","author":"S Ashkenazi","year":"2003","unstructured":"Ashkenazi S, Levy I, Kazaronovsky V, Samra Z (2003) Growing antimicrobial resistance of Shigella isolates. J Antimicrob Chemother 51:427\u2013429","journal-title":"J Antimicrob Chemother"},{"key":"24_CR3","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1128\/IAI.62.11.5168-5172.1994","volume":"62","author":"FR Noriega","year":"1994","unstructured":"Noriega FR, Wang JY, Losonsky G, Maneval DR et al (1994) Construction and characterization of attenuated (delta)aroA (delta)virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine. Infect Immun 62:5168\u20135172","journal-title":"Infect Immun"},{"key":"24_CR4","doi-asserted-by":"publisher","first-page":"S285","DOI":"10.1093\/clinids\/13.Supplement_4.S285","volume":"13","author":"PJ Sansonetti","year":"1991","unstructured":"Sansonetti PJ (1991) Genetic and molecular basis of epithelial cell invasion by Shigella species. Rev Infect Dis 13:S285\u2013S292","journal-title":"Rev Infect Dis"},{"key":"24_CR5","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1128\/IAI.61.6.2390-2395.1993","volume":"61","author":"N Orr","year":"1993","unstructured":"Orr N, Robin G, Cohen D, Arnon R, Lowell GH (1993) Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models. Infect Immun 61:2390\u20132395","journal-title":"Infect Immun"},{"key":"24_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0140-6736(96)06255-1","volume":"349","author":"D Cohen","year":"1997","unstructured":"Cohen D, Ashkenazi S, Green MS, Gdalevich M, Robin G, Slepon R et al (1997) Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults. Lancet 349:155\u2013159","journal-title":"Lancet"},{"key":"24_CR7","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1128\/IAI.59.10.3610-3618.1991","volume":"59","author":"VI Levenson","year":"1991","unstructured":"Levenson VI, Egorova TP, Belkin ZP, Fedosova VG, Subbotina JL, Rukhadze EZ et al (1991) Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine. Infect Immun 59:3610\u20133618","journal-title":"Infect Immun"},{"key":"24_CR8","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1128\/IAI.69.3.1351-1357.2001","volume":"69","author":"JH Passwell","year":"2001","unstructured":"Passwell JH, Harlev E, Ashkenazi S, Chu C, Miron D, Ramon R et al (2001) Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel. Infect Immun 69:1351\u20131357","journal-title":"Infect Immun"},{"key":"24_CR9","first-page":"3728","volume":"24","author":"EM Berry","year":"2006","unstructured":"Berry EM, Wang J, Wu T, Davis T, Levine MM (2006) Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model. Vaccine 24:3728\u20133734","journal-title":"Vaccine"},{"key":"24_CR10","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.vaccine.2007.12.040","volume":"26","author":"KR Turbyfill","year":"2008","unstructured":"Turbyfill KR, Kaminski RW, Oaks EV (2008) Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2a. Vaccine 26:1353\u20131364","journal-title":"Vaccine"},{"key":"24_CR11","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/IAI.67.7.3437-3443.1999","volume":"67","author":"TS Coster","year":"1999","unstructured":"Coster TS, Charles HW, Lillian L, VanDeVerg A, Hartman AB et al (1999) Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602. Infect Immun 67:3437\u20133443","journal-title":"Infect Immun"},{"key":"24_CR12","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1128\/IAI.68.3.1034-1039.2000","volume":"68","author":"KL Kotloff","year":"2000","unstructured":"Kotloff KL, Noriega FR, Samandari T, Sztein MB, Losonsky GA et al (2000) Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans. Infect Immun 68:1034\u20131039","journal-title":"Infect Immun"},{"key":"24_CR13","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1016\/j.vaccine.2004.01.038","volume":"22","author":"X Peng","year":"2004","unstructured":"Peng X, Ye X, Wang S (2004) Identification of novel immunogenic proteins of Shigella flexneri 2a by proteomic methodologies. Vaccine 22:2750\u20132756","journal-title":"Vaccine"},{"key":"24_CR14","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/j.1365-2672.2007.03359.x","volume":"103","author":"F Dumetz","year":"2007","unstructured":"Dumetz F, LaPatra SE, Duchaud E, Claverol S, Henaff ML (2007) The Flavobacterium psychrophilum OmpA, an outer membrane glycoprotein, induces a humoral response in rainbow trout. J Appl Microbiol 103:1461\u20131470","journal-title":"J Appl Microbiol"},{"key":"24_CR15","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.1016\/j.vaccine.2009.07.054","volume":"27","author":"D Pore","year":"2009","unstructured":"Pore D, Chowdhury P, Mahata N, Pal A, Yamasaki S, Mahalanabis D, Chakrabarti MK (2009) Purification and characterization of an immunogenic outer membrane protein of Shigella flexneri 2a. Vaccine 27:5855\u20135864","journal-title":"Vaccine"},{"key":"24_CR16","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.molimm.2010.03.001","volume":"47","author":"D Pore","year":"2010","unstructured":"Pore D, Mahata N, Pal A, Chakrabarti MK (2010) 34 kDa MOMP of Shigella flexneri promotes TLR2 mediated macrophage activation with the engagement of NF-\u03baB and p38 MAP kinase signaling. Mol Immunol 47:1739\u20131746","journal-title":"Mol Immunol"},{"issue":"7","key":"24_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022663","volume":"6","author":"D Pore","year":"2011","unstructured":"Pore D, Mahata N, Pal A, Chakrabarti MK (2011) Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model. PLoS One 6(7), e22663","journal-title":"PLoS One"},{"key":"24_CR18","doi-asserted-by":"publisher","first-page":"12589","DOI":"10.1074\/jbc.M111.335554","volume":"287","author":"D Pore","year":"2012","unstructured":"Pore D, Mahata N, Chakrabarti MK (2012) Outer membrane protein A (OmpA) of Shigella flexneri 2a links innate and adaptive immunity in a TLR2 dependent manner and with the involvement of IL-12 and nitric oxide (NO). J Biol Chem 287:12589\u201312601","journal-title":"J Biol Chem"},{"key":"24_CR19","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1016\/j.vaccine.2013.05.100","volume":"31","author":"D Pore","year":"2013","unstructured":"Pore D, Chakrabarti MK (2013) Outer membrane protein A (OmpA) from Shigella flexneri 2a: a promising subunit vaccine candidate. Vaccine 31:3644\u20133650","journal-title":"Vaccine"},{"issue":"10","key":"24_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109107","volume":"9","author":"R Bhowmick","year":"2014","unstructured":"Bhowmick R, Pore D, Chakrabarti MK (2014) Outer membrane protein A (OmpA) of Shigella flexneri 2a induces TLR2-mediated activation of B cells: involvement of protein tyrosine kinase, ERK and NF-\u03baB. PLoS One 9(10), e109107","journal-title":"PLoS One"},{"key":"24_CR21","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1128\/JB.115.3.717-722.1973","volume":"115","author":"C Filip","year":"1973","unstructured":"Filip C, Fletcher G, Wullf JL, Earhart CF (1973) Solubilization of the cytoplasmic membrane Escherichia coli by the ionic detergent sodium lauryl sarcosinate. J Bacteriol 115:717\u2013722","journal-title":"J Bacteriol"},{"key":"24_CR22","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1126\/science.284.5418.1313","volume":"284","author":"JA Hoffmann","year":"1999","unstructured":"Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA (1999) Phylogenetic perspectives in innate immunity. Science 284:1313\u20131318","journal-title":"Science"},{"key":"24_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","volume":"7","author":"TR Mosmann","year":"1989","unstructured":"Mosmann TR, Coffman RL (1989) TH1 and TH2 cells. Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145\u2013173","journal-title":"Annu Rev Immunol"},{"key":"24_CR24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.coi.2007.04.002","volume":"19","author":"A Lanzavecchia","year":"2007","unstructured":"Lanzavecchia A, Sallusto F (2007) Toll-like receptors and innate immunity in B cell activation and antibody responses. Curr Opin Immunol 19:268\u2013274","journal-title":"Curr Opin Immunol"},{"key":"24_CR25","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/0264-410X(93)90016-Q","volume":"11","author":"CP Mallett","year":"1993","unstructured":"Mallett CP, VanDeVerg L, Collins HH, Hale TL (1993) Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model. Vaccine 11:190\u2013196","journal-title":"Vaccine"}],"container-title":["Methods in Molecular Biology","Vaccine Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3387-7_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T17:24:46Z","timestamp":1600449886000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-3387-7_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493933853","9781493933877"],"references-count":25,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3387-7_24","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"14 April 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}